The biopharmaceutical division develops, produces and markets prescription drugs for the therapeutic areas of Neurodegenerative Diseases, Oncology, Fertility, Endocrinology, CardioMetabolic Care and General Medicine.
In oncology, we are focusing on therapeutic options that systematically target the tumor. The key is finding the right combination. This refers both to the targets of a therapy in the disease process and to the combination possibilities with standard therapies such as radiation or chemotherapy.
We offer a comprehensive range of therapeutic options for cardiovascular diseases, diabetes and thyroid diseases, thus making a significant contribution to effective treatment of often complex symptoms.